Job Description
- Creation and execution of the risk-based audit plan, reporting results to Intas Leadership and the Audit Committee of the Board of Directors.
- Manage wide-ranging scope of audits with an emphasis on assessing emerging areas of risk including revenue recognition, contract accounting, compliance, fraud, operations and outsourcing.
- Managing the fieldwork, work paper documentation, audit meetings, reporting, and follow-ups; ensuring that methodologies governing internal audits are followed.
- Leverage the power of data analytics and automation techniques to achieve comprehensive risk coverage and deliver high-quality audit results.
- Through interaction with auditees and team members, develop strong professional relationships that foster trust and collaboration and set a solid example for others.
- Keep abreast of company policies and procedures, current developments in accounting and auditing professions.
- Work with multinational auditees and flexibility to work across time zones.
Desired Skills and qualifications:
- Chartered Accountant with 6 - 12 years of post-qualification experience in external or internal auditing. Experience in Big 4 or a global organization will be preferred.
- Highly motivated and self-driven with limited guidance from the supervisor.
- Experience in data analytics in audit lifecycle.
- Strong working knowledge of financial, operational, compliance, and systems auditing techniques.
- Strong verbal and written communication, report drafting, and presentation skills, and proficiency with the English language.
- Ability to think outside the box and challenge the status quo.
- Must be able to work in a dynamic and fast-paced environment with flexibility to adjust to time zones.
- Additional relevant professional or technical certifications (CIA or CFE) is preferred.
- Readiness for domestic and international travel.
More Info
Key Skills
About Company
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business.
Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK.
Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests 6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products.
Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies.
The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab.
Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.